BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
SillaJen, Inc.
SillaJen, Inc.
University of Michigan Rogel Cancer Center
AstraZeneca
Nurix Therapeutics, Inc.
Merck Sharp & Dohme LLC
First Affiliated Hospital of Zhejiang University
Jazz Pharmaceuticals
Nektar Therapeutics
AIDS Malignancy Consortium
AbbVie
City of Hope Medical Center
Hanmi Pharmaceutical Company Limited
University of California, San Francisco
National Cancer Institute (NCI)